SCHEMBL230036

SCHEMBL230036

O=C(CCl)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL960143 0.83 ALDH1A1 (0.77)
SCHEMBL711360 0.82 RAB9A (0.75)
SCHEMBL2216212 0.82 ALDH1A1 (1.00)
SCHEMBL2209532 0.80 ALDH1A1 (0.71)
SCHEMBL23855456 0.80
SCHEMBL5762863 0.80 GSK3B (0.66)
SCHEMBL4852587 0.79 HPGD (0.70)
SCHEMBL658097 0.78
SCHEMBL22721189 0.78 ALDH1A1 (0.83)
SCHEMBL11407883 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111205266-B Synthetic method of 2-thiopheneacetic acid 辽宁九华化工有限公司 2022-11-04 CN claimed
CN-111205266-A Synthetic method of 2-thiopheneacetic acid 辽宁九华化工有限公司 2020-05-29 CN claimed
CN-105085469-A Preparation method of 5-chlorothienyl-2-carboxylic acid CANGZHOU SENARY CHEMICAL SCIENCE TEC CO LTD 2015-11-25 CN claimed
EP-2034011-B1 CELL CLUSTER COMPRISING PLURAL KINDS OF CELLS DERIVED FROM SOMA WITH ABILITY TO FORM PRIMITIVE ORGAN-LIKE STRUCTURE SHISEIDO CO LTD (JP) 2013-05-22 EP claimed
US-20090306045-A1 Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-12-10 US claimed
WO-2007075911-A2 INHIBITION OF GLYCOGEN SYNTHASE KINASE AND METHODS OF TREATING AUTOIMMUNE OR IMMUNE INFLAMMATORY DISEASE YALE UNIVERSITY (US) 2007-07-05 WO claimed
EP-1243581-B1 Pyridinium compounds useful for the treatment of AGE-related diseases TORRENT PHARMACEUTICALS LTD (IN) 2005-07-13 EP claimed
JP-1019006-A None JP disclosed
CN-118184625-A Synthesis method of 2-thiopheneacetic acid 浙江东盈药业有限公司 2024-06-14 CN disclosed
US-11746331-B2 Endodermal cell population, and method for producing cell population of any of three germ layers from pluripotent cell KANEKA CORPORATION 2023-09-05 US disclosed
EP-4194549-A1 ENDODERMAL CELL POPULATION, AND METHOD FOR PRODUCING CELL POPULATION OF ANY OF THREE GERM LAYERS FROM PLURIPOTENT CELL Kaneka Corporation (JP) 2023-06-14 EP disclosed
US-20230174945-A1 METHOD FOR INDUCING DIFFERENTIATION INTO PANCREATIC ALPHA CELLS KANEKA CORPORATION (JP) 2023-06-08 US disclosed
CN-114605375-B Synthetic method of 2-thiopheneacetic acid 沈阳化工研究院有限公司 2023-04-11 CN disclosed
US-4258040-A Cephalosporin compounds MERCK & CO., INC. (US) 1981-03-24 US disclosed
US-4105663-A HYPOTENSIVE, BLOCKING AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1978-08-08 US disclosed
US-4093628-A HYPOTENSIVE AGENTS, BLOCKING AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1978-06-06 US disclosed
US-4082772-A HYPOTENSIVE AGENTS, B-ADRENERGIC BLOCKING AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1978-04-04 US disclosed
US-4060687-A Cephalosporins having a 3-α substituted alkyl grouping MERCK & CO., INC. (US) 1977-11-29 US disclosed
US-4024156-A Thiophene ethanolamines AMERICAN HOME PRODUCTS CORPORATION (US) 1977-05-17 US disclosed
US-3947413-A ANTIBIOTICS MERCK & CO., INC. (US) 1976-03-30 US disclosed